<- Go Home
Microbot Medical Inc.
Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body’s vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts
Market Cap
$145.7M
Volume
2.8M
Cash and Equivalents
$3.7M
EBITDA
-$16.0M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$2.0K
Profit Margin
1.90%
52 Week High
$4.67
52 Week Low
$1.60
Dividend
N/A
Price / Book Value
1.97
Price / Earnings
-8.37
Price / Tangible Book Value
1.97
Enterprise Value
$74.1M
Enterprise Value / EBITDA
-4.71
Operating Income
-$16.0M
Return on Equity
27.58%
Return on Assets
-18.40
Cash and Short Term Investments
$72.5M
Debt
$898.0K
Equity
$74.1M
Revenue
$105.0K
Unlevered FCF
-$11.6M
Sector
Health Care Equipment and Supplies
Category
N/A